Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Yana Pikman, M.D.

Concepts (258)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Yana Pikman's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Yana Pikman has written about over time.
Myeloproliferative Disorders, 6 publications between 2005 and 2024, average publication date December 2009. Oncogene Proteins, Fusion, 5 publications between 2006 and 2023, average publication date January 2016. Citric Acid Cycle, 1 publications between 2016 and 2016, average publication date June 2016. Methenyltetrahydrofolate Cyclohydrolase, 1 publications between 2016 and 2016, average publication date June 2016. Cyclin-Dependent Kinase 4, 1 publications between 2016 and 2016, average publication date November 2016. Purines, 1 publications between 2016 and 2016, average publication date November 2016. Hematologic Neoplasms, 3 publications between 2006 and 2023, average publication date February 2017. Gene Expression Regulation, Leukemic, 4 publications between 2016 and 2022, average publication date April 2019. Leukemia, 2 publications between 2018 and 2021, average publication date November 2019. Lymphoma, T-Cell, 1 publications between 2020 and 2020, average publication date April 2020. Precursor Cell Lymphoblastic Leukemia-Lymphoma, 5 publications between 2016 and 2023, average publication date June 2020. Leukemia, Myeloid, Acute, 14 publications between 2014 and 2024, average publication date November 2020. Hematologic Diseases, 1 publications between 2020 and 2020, average publication date December 2020. Folic Acid, 2 publications between 2020 and 2021, average publication date February 2021. Enzyme Inhibitors, 3 publications between 2018 and 2023, average publication date March 2021. Methotrexate, 1 publications between 2021 and 2021, average publication date August 2021. Glycine Hydroxymethyltransferase, 2 publications between 2021 and 2022, average publication date October 2021. Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, 4 publications between 2020 and 2023, average publication date July 2022. Down Syndrome, 2 publications between 2022 and 2024, average publication date March 2023. Leukemoid Reaction, 2 publications between 2022 and 2024, average publication date March 2023.

To see the data from this visualization as text, click here.
Pikman's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (258)
Explore
_
Co-Authors (102)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.